Articles Companion animals

11 August 2026

2025 iCatCare consensus guidelines on the diagnosis and management of lower urinary tract diseases in cats.

Clinical evidence update from Journal of feline medicine and surgery

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Journal of feline medicine and surgery in 2025 evaluated 2025 iCatCare consensus guidelines on the diagnosis and management of lower urinary tract diseases in cats..

Key Findings

Lower urinary tract signs (LUTS) such as dysuria, haematuria, periuria, pollakiuria and stranguria can occur as the result of a variety of underlying conditions and diagnostic investigation is required to uncover the underlying cause and select appropriate treatment. The '2025 iCatCare consensus guidelines on the diagnosis and management of lower urinary tract diseases in cats' provide an overview of the common presenting signs caused by underlying feline lower urinary tract (LUT) diseases in cats, which often are indistinguishable between different underlying causes. The Guidelines set out a diagnostic approach to affected cats before...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

News of interest

Multilevel analysis of risk factors for clinical mastitis in dairy cows in Plateau State, Nigeria a hierarchical mixed-effects logistic regression modelling approach.

Long term safety and efficacy of a functionalized nanogel with endothelin-1 and bradykinin receptor antagonist peptides for treatment of osteoarthritis of the metacarpophalangeal and distal interphalangeal joints in horses

Strategies for Reducing Antimicrobial Use in Cattle Through Gut Microbiome Modulation A Systematic Review of Alternatives to Antibiotics.

Exploration of the efficacy of eucalyptus oil (micro-capsules) and mangosteen extract against Eimeria tenella infection in chickens.

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

2025 iCatCare consensus guidelines on the diagnosis and management of lower urinary tract diseases in cats.

Clinical evidence update from Journal of feline medicine and surgery

Comments

List

Add

Tag

Related Articles

10 August 2026
Homeopathy for Enterotoxigenic Escherichia coli Diarrhoea in Weaned Piglets Study Protocol for a Randomised, Double-Blind, Placebo-Controlled Clinical Trial (the ETEC-HOM Trial).

Homeopathy for Enterotoxigenic Escherichia coli Diarrhoea in Weaned Piglets Study Protocol for a Randomised, Double-Blind, Placebo-Controlled Clinical Trial (the ETEC-HOM Trial).

10 August 2026
Ureteroneocystostomy as a treatment for benign ureteral obstruction and ectopic ureter in cats 37 cases.

Ureteroneocystostomy as a treatment for benign ureteral obstruction and ectopic ureter in cats 37 cases.

10 August 2026
A Retrospective Comparison of Survival, Tumour Reduction and Relapse Outcomes Following Oclacitinib and CCNU Treatment in Dogs With Canine Epitheliotropic T-Cell Lymphoma.

A Retrospective Comparison of Survival, Tumour Reduction and Relapse Outcomes Following Oclacitinib and CCNU Treatment in Dogs With Canine Epitheliotropic T-Cell Lymphoma.

07 August 2026
The Potential for Sample Testing at the Pen Level to Inform Prudent Antimicrobial Selection for Bovine Respiratory Disease Treatment Investigations Using a Feedlot Simulation Tool.

The Potential for Sample Testing at the Pen Level to Inform Prudent Antimicrobial Selection for Bovine Respiratory Disease Treatment Investigations Using a Feedlot Simulation Tool.

07 August 2026
Evaluation of the effect of Renaltec in cats with IRIS stage 2 and 3 chronic kidney disease.

Evaluation of the effect of Renaltec in cats with IRIS stage 2 and 3 chronic kidney disease.

More news

Survival of dogs with glomerular disease in Europe insights from the European Veterinary Renal Pathology Service.

Determinants of mortality from bovine respiratory disease in Australian feedlot cattle A survival analysis.

FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma